Literature DB >> 21810532

Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Jane A Cauley1, Ghada El-Hajj Fuleihan, Asma Arabi, Saeko Fujiwara, Sergio Ragi-Eis, Andrew Calderon, Siok Bee Chionh, Zhao Chen, Jeffrey R Curtis, Michelle E Danielson, David A Hanley, Heikki Kroger, Annie W C Kung, Olga Lesnyak, Jeri Nieves, Wojciech Pluskiewicz, Rola El Rassi, Stuart Silverman, Anne-Marie Schott, Rene Rizzoli, Marjorie Luckey.   

Abstract

Osteoporosis is a serious worldwide epidemic. Increased risk of fractures is the hallmark of the disease and is associated with increased morbidity, mortality and economic burden. FRAX® is a web-based tool developed by the Sheffield WHO Collaborating Center team, that integrates clinical risk factors, femoral neck BMD, country specific mortality and fracture data and calculates the 10 year fracture probability in order to help health care professionals identify patients who need treatment. However, only 31 countries have a FRAX® calculator at the time paper was accepted for publication. In the absence of a FRAX® model for a particular country, it has been suggested to use a surrogate country for which the epidemiology of osteoporosis most closely approximates the index country. More specific recommendations for clinicians in these countries are not available. In North America, concerns have also been raised regarding the assumptions used to construct the US ethnic specific FRAX® calculators with respect to the correction factors applied to derive fracture probabilities in Blacks, Asians and Hispanics in comparison to Whites. In addition, questions were raised about calculating fracture risk in other ethnic groups e.g., Native Americans and First Canadians. In order to provide additional guidance to clinicians, a FRAX® International Task Force was formed to address specific questions raised by physicians in countries without FRAX® calculators and seeking to integrate FRAX® into their clinical practice. The main questions that the task force tried to answer were the following: The Task Force members conducted appropriate literature reviews and developed preliminary statements that were discussed and graded by a panel of experts at the ISCD-IOF joint conference. The statements approved by the panel of experts are discussed in the current paper.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21810532     DOI: 10.1016/j.jocd.2011.05.015

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  29 in total

Review 1.  Geographic and ethnic disparities in osteoporotic fractures.

Authors:  Jane A Cauley; Didier Chalhoub; Ahmed M Kassem; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2014-04-22       Impact factor: 43.330

2.  Cortical microstructure compensates for smaller bone size in young Caribbean Hispanic versus non-Hispanic white men.

Authors:  M D Walker; A Kepley; K Nishiyama; B Zhou; E Guo; T L Nickolas
Journal:  Osteoporos Int       Date:  2017-03-24       Impact factor: 4.507

3.  FRAX and ethnicity.

Authors:  J A Kanis; C Cooper; B Dawson-Hughes; N C Harvey; H Johansson; M Lorentzon; E V McCloskey; J-Y Reginster; R Rizzoli
Journal:  Osteoporos Int       Date:  2020-09-04       Impact factor: 4.507

Review 4.  Osteoporotic hip and vertebral fractures in the Arab region: a systematic review.

Authors:  M Barake; R El Eid; S Ajjour; M Chakhtoura; L Meho; T Mahmoud; J Atieh; A M Sibai; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2021-04-07       Impact factor: 4.507

5.  FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.

Authors:  R C Hamdy; E Seier; K Whalen; W A Clark; K Hicks; T B Piggee
Journal:  Osteoporos Int       Date:  2018-02-03       Impact factor: 4.507

6.  Ethnic variability in bone geometry as assessed by hip structure analysis: findings from the hip strength across the menopausal transition study.

Authors:  Michelle E Danielson; Thomas J Beck; Yinjuan Lian; Arun S Karlamangla; Gail A Greendale; Kristine Ruppert; Joan Lo; Susan Greenspan; Marike Vuga; Jane A Cauley
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

Review 7.  Osteoporosis in men: recent progress.

Authors:  Robert A Adler
Journal:  Endocrine       Date:  2013-01-25       Impact factor: 3.633

8.  Fracture risk assessment without race/ethnicity information.

Authors:  Shinya Ishii; Gail A Greendale; Jane A Cauley; Carolyn J Crandall; Mei-Hua Huang; Michelle E Danielson; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2012-08-03       Impact factor: 5.958

9.  Systemic markers of microvascular disease and bone mineral density in older adults : The cardiovascular health study.

Authors:  J I Barzilay; P Bůžková; H A Fink; J A Cauley; J A Robbins; P S Garimella; D I Jalal; K J Mukamal
Journal:  Osteoporos Int       Date:  2016-06-01       Impact factor: 4.507

10.  Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.

Authors:  Kathleen Mulligan; D Robert Harris; Patricia Emmanuel; Roger A Fielding; Carol Worrell; Bill G Kapogiannis; Dina Monte; John Sleasman; Craig M Wilson; Grace M Aldrovandi
Journal:  Clin Infect Dis       Date:  2012-05-09       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.